News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
CLL12 study supports using the watch-and-wait approach for early-stage CLL
Petra Langerbeins/touchoncology.com
Feb 1, 2025, 13:44

CLL12 study supports using the watch-and-wait approach for early-stage CLL

Jonathan Friedberg, Director of Wilmot Cancer Institute, shared a recent article by Petra Langerbeins, et al. on X:

CLL12 study supports using the watch-and-wait approach as the standard of care for early-stage CLL, including high-risk patients.

Ongoing SWOG Cancer Research Network S1925 trial evaluates early venetoclax-based treatment for high risk patients.

Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial

Authors: Petra Langerbeins, et al.

CLL12 study supports using the watch-and-wait approach for early-stage CLL

cancer CLL CLL12 Jonathan Friedberg OncoDaily Oncology Petra Langerbeins S1925 trial SWOG Cancer Research Network venetoclax Wilmot Cancer Institute
Special Coverage
OncoDaily Pulse
Sep 9, 2025, 02:16
Join Us for Global Voices in Renal Oncology Virtual Congress 2025
Voices
Sep 9, 2025, 02:03
Shaheenah Dawood: Addition of Osimertinib to Neoadjuvant Chemotherapy
Societies
Sep 9, 2025, 01:48
General Approach to AI in Paediatric Health Informatics - SIOP
Voices
Sep 9, 2025, 01:43
Catherine Alix-Panabières Opens Svedberg Seminar Series on Liquid Biopsy
Voices
Sep 9, 2025, 00:59
Take Part in the Safari With My Book Challenge - ACREOL Global
Voices
Sep 9, 2025, 00:46
Al-Ola A Abdallah: Prerna Mewawalla to Present CAR-T Advances in Myeloma
Voices
Sep 8, 2025, 18:14
Gerardo Rodríguez-Lobato: Shared Insights on CARTs in Myeloma at the ITCTC25
Science
Sep 8, 2025, 17:37
Gustavo Viani: Changing the Standard in High-Risk Endometrial Cancer
Voices
Sep 8, 2025, 17:13
Sushil Beriwal: Productive and Informative Sessions at the 2025 Varian Oncology Summit
Science
Sep 8, 2025, 16:59
Vincent Rajkumar: Fantastic New Article on Survival in Essential Thrombocythemia
Voices
Sep 8, 2025, 16:57
Paolo Ascierto: A Program Dedicated to Melanoma Prevention
Voices
Sep 8, 2025, 16:48
Roxana-Elena Cãlescu’s Experience in Gastrointestinal Oncology Through the M2ICOS Project - ESO